Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP748145.RACpeFDGZJzynnnimRwNRABNL2tMedJ1qhsLRHt5YL9M4130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP748145.RACpeFDGZJzynnnimRwNRABNL2tMedJ1qhsLRHt5YL9M4130_provenance.
• NP277833.RA6NRmW-veQ52aPmcbeJtObbXV6SkpK25mhI_54U5m6Go130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP277833.RA6NRmW-veQ52aPmcbeJtObbXV6SkpK25mhI_54U5m6Go130_provenance.
• assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP625120.RA-8iTnM2rduHzG14Gdh_T7o7c8R4Wl-0QZA5AHigqSYU130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625120.RA-8iTnM2rduHzG14Gdh_T7o7c8R4Wl-0QZA5AHigqSYU130_provenance.
• assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP299051.RAfzcToTzCuj-ZVyEN-7KGOtdmtzLcFKHWYFcUwSHnfJ4130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299051.RAfzcToTzCuj-ZVyEN-7KGOtdmtzLcFKHWYFcUwSHnfJ4130_provenance.
• NP889751.RAT3JYjwcAexdU7k8U0N8db5dTRERD5_DZXxrRuXcGYaI130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP889751.RAT3JYjwcAexdU7k8U0N8db5dTRERD5_DZXxrRuXcGYaI130_provenance.
• assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP299049.RACV6yinWEQ9J52Am8AAOmkvjk8zo8EjMvqZOmuX4ql7k130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299049.RACV6yinWEQ9J52Am8AAOmkvjk8zo8EjMvqZOmuX4ql7k130_provenance.
• NP299048.RAplFJ2ZOUc1DJ-bVVTYxiiSZN_Bcurp3WGwnqk2rmbdU130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299048.RAplFJ2ZOUc1DJ-bVVTYxiiSZN_Bcurp3WGwnqk2rmbdU130_provenance.
• NP450337.RApk9kX0kBXIB7Kr6XBBswyJNo3Jcg1rWXzMnADZ7J7BY130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450337.RApk9kX0kBXIB7Kr6XBBswyJNo3Jcg1rWXzMnADZ7J7BY130_provenance.
• NP923475.RAkmQbWIX3ri0f_VUlKAlyITbaR5rS4jNqy7R0VEhxZ_E130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923475.RAkmQbWIX3ri0f_VUlKAlyITbaR5rS4jNqy7R0VEhxZ_E130_provenance.
• NP923476.RAq7CehcUJGEcgDIgtfLAOVHZjB5JoNHh710DHTUllX2U130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923476.RAq7CehcUJGEcgDIgtfLAOVHZjB5JoNHh710DHTUllX2U130_provenance.
• NP450331.RAMzh6oe6idUbEDx_ac5zAwtBCojPUKShAzt9SCSs7dMc130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450331.RAMzh6oe6idUbEDx_ac5zAwtBCojPUKShAzt9SCSs7dMc130_provenance.
• NP450355.RAOOeGS0CFlnTVEfRZi-NP1x8DOO5-caIatF0sTogUOIU130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450355.RAOOeGS0CFlnTVEfRZi-NP1x8DOO5-caIatF0sTogUOIU130_provenance.
• NP889757.RANdMU3F-H5lKBFdUnjfkqX66dGJvMwGXS46DTAOZeUMo130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP889757.RANdMU3F-H5lKBFdUnjfkqX66dGJvMwGXS46DTAOZeUMo130_provenance.
• NP923470.RAGqtLz04ehwvEoGlHsc3oB1tyCQoMATczNUnYqz8YLBw130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923470.RAGqtLz04ehwvEoGlHsc3oB1tyCQoMATczNUnYqz8YLBw130_provenance.
• NP923481.RAErSoohgHqdKSGELhhdssAjg5dbO8cBJc0SLTBO2xAZM130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923481.RAErSoohgHqdKSGELhhdssAjg5dbO8cBJc0SLTBO2xAZM130_provenance.
• NP889776.RA2Cayja_kAdhxLZUFmurb0UHoG3Q6BlSJcgTeamqcqSw130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP889776.RA2Cayja_kAdhxLZUFmurb0UHoG3Q6BlSJcgTeamqcqSw130_provenance.
• NP923471.RA_hmWEQrGZaygy8UzRKcromY2eCJ6yv6whhP2ld4ESOg130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923471.RA_hmWEQrGZaygy8UzRKcromY2eCJ6yv6whhP2ld4ESOg130_provenance.
• NP923473.RAyeRqxqATCXjC4lUnEJUrdXxPCoMwWDdH_btZ-_X1Fxc130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923473.RAyeRqxqATCXjC4lUnEJUrdXxPCoMwWDdH_btZ-_X1Fxc130_provenance.
• NP923474.RA5lkOBgTnmYDsVg9K4BozoOHI2kr8_k60DYffay7C3BE130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923474.RA5lkOBgTnmYDsVg9K4BozoOHI2kr8_k60DYffay7C3BE130_provenance.
• NP923478.RA1eBNl0GF00d0U-B826L2Gdd4a75rFNazHUt2G9cdVvg130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923478.RA1eBNl0GF00d0U-B826L2Gdd4a75rFNazHUt2G9cdVvg130_provenance.
• NP923479.RA805RQLrCJeC4z3sIyN6hAA0Xw1rGATk4kVpdV0tzoJM130_assertion description "[Activation of NF-kappa B, increase of E2-EPF ubiquitin carrier protein and subsequent epithelial-mesenchymal transition might be the underlying mechanisms of the more aggressive tumor growth in IL-1 beta-positive esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923479.RA805RQLrCJeC4z3sIyN6hAA0Xw1rGATk4kVpdV0tzoJM130_provenance.